Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
MYGN
Chart

Myriad Genetics Inc

MYGN

Jan 1 1970 00:00:00
4.21
▲0.05000▲1.20%
4.10
4.24
4.02
4.16
118.86k
-1.41
-2.99
384.41M
91.31M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-10-10
Form 4
ID: 0001517026-24-000006
2024-10-10
Form 4
ID: 0001922964-24-000008
2024-10-10
Form 4
ID: 0001843872-24-000004
2024-10-09
Form 8-K
ID: 0000899923-24-000048
2024-09-23
Form 4
ID: 0001517026-24-000004
2024-09-23
Form 4
ID: 0001843568-24-000006
2024-09-23
Form 4
ID: 0001932320-24-000008
2024-09-16
Form 144
ID: 0002002698-24-000419
2024-09-12
Form 4
ID: 0001628280-24-040232
2024-09-12
Form 4
ID: 0001922964-24-000006

You might find these companies interesting

TNFA
Tnf Pharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
VNRX
Volitionrx Ltd
In Vitro & In Vivo Diagnostic Substances (2835)
NTLA
Intellia Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
TRIB
Trinity Biotech Plc
In Vitro & In Vivo Diagnostic Substances (2835)
NEOG
Neogen Corp
In Vitro & In Vivo Diagnostic Substances (2835)
ICCC
Immucell Corp /De/
In Vitro & In Vivo Diagnostic Substances (2835)
VRAX
Virax Biolabs Group Ltd
In Vitro & In Vivo Diagnostic Substances (2835)
ORKA
Oruka Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
IDXX
Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances (2835)
CLDX
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
NAVB
Navidea Biopharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
MYMD
Mymd Pharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
SPRY
Ars Pharmaceuticals, Inc.
Pharmaceutical Preparations (2834)
NKTR
Nektar Therapeutics
Pharmaceutical Preparations (2834)